Related Experiment Video
Updated: May 31, 2026

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
Published on: August 1, 2017
Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors
Yusuke Shiozawa1, Kenneth J Pienta, Russell S Taichman
1Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
Abstract:
Despite significant improvements in therapy, the prognosis for cancer with bone metastasis is generally poor. Therefore, there is a great need for new therapeutic approaches for metastatic disease. It has been appreciated that tumor cells metastasize to bone using mechanisms similar to those of hematopoietic stem cells (HSC) homing to bone marrow (e.g., CXCL12/CXCR4). It was recently found that prostate cancer cells target the bone marrow microenvironment for HSCs, or the HSC niche, during metastasis. Of importance, these disseminated prostate cancer cells can be mobilized out of the niche with the use of HSC mobilizing agents. These findings suggest that the bone marrow HSC niche is a potential therapeutic target for metastatic disease. Therefore, a hypothesis worth considering is that agents that can disrupt the interactions between tumor cells and the HSC niche may be efficacious when used in conjunction with standard chemotherapeutic agents. Although further understanding of the tumor-niche interactions is needed, the concept of targeting the niche in conjunction with chemotherapy could open up new possibilities to eradicate incurable metastatic diseases.
Insights
Targeting the bone marrow
Area of Science:
- Oncology and Stem Cell Biology
Background:
- Cancer metastasis to bone remains a significant therapeutic challenge.
- Tumor cells utilize mechanisms similar to hematopoietic stem cell (HSC) homing to bone marrow.
- Prostate cancer cells specifically target the HSC niche in the bone marrow.
Purpose of the Study:
- To explore the bone marrow HSC niche as a therapeutic target for metastatic cancer.
- To investigate the potential of disrupting tumor-cell/niche interactions for improved cancer treatment.
Main Methods:
- The study reviews existing literature on tumor cell metastasis and HSC homing mechanisms.
- It discusses the implications of targeting the HSC niche with mobilizing agents.
- The concept of combining niche-disrupting agents with chemotherapy is explored.
Main Results:
- Disseminated tumor cells within the HSC niche can be mobilized using HSC mobilizing agents.
- The bone marrow HSC niche presents a viable therapeutic target for metastatic disease.
- Disrupting tumor-cell/niche interactions may enhance the efficacy of chemotherapy.
Conclusions:
- Targeting the bone marrow HSC niche offers a novel strategy for treating metastatic cancer.
- Combining niche-targeting agents with chemotherapy holds promise for eradicating incurable metastatic diseases.
- Further research into tumor-niche interactions is crucial for developing effective therapies.
More Related Videos
11:06Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
Published on: March 21, 2017
08:34Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells
Published on: September 28, 2022
Related Concept Videos
Stem Cell Niche
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Hematopoiesis
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...